Perivascular Fat, Inflammation, and Cardiovascular Risk in HIV-infected Patients on Antiretroviral Therapy

Documenti analoghi

• Markers of inflammation and CD8+ T-cell activation, but not monocyte activation are associated with subclinical carotid artery disease in HIV
  di: Longenecker, Chris T., et al.
  Pubblicazione: (2013)
• Bone turnover, OPG/RANKL, and inflammation with antiretroviral initiation: comparison of tenofovir- vs. non-tenofovir regimens
  di: T. Brown, Todd, et al.
  Pubblicazione: (2011)
• Rosuvastatin Treatment Reduces Markers of Monocyte Activation in HIV-Infected Subjects on Antiretroviral Therapy
  di: Funderburg, Nicholas T., et al.
  Pubblicazione: (2014)
• Rosuvastatin reduces vascular inflammation and T cell and monocyte activation in HIV-infected subjects on antiretroviral therapy
  di: Funderburg, Nicholas T., et al.
  Pubblicazione: (2015)
• Relationship between total bilirubin, endothelial function, inflammation and oxidative stress in HIV-infected adults on stable antiretroviral therapy
  di: Hileman, Corrilynn O., et al.
  Pubblicazione: (2012)